Application Nr Approved Date Route Status External Links
ANDA202961 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Oxcarbazepine Oral Suspension Is Indicated For Use As Monotherapy Or Adjunctive Therapy In The Treatment Of Partial-Onset Seizures In Adults And As Monotherapy In The Treatment Of Partial-Onset Seizures In Pediatric Patients Aged 4 Years And Above, And As Adjunctive Therapy In Pediatric Patients Aged 2 Years And Above With Partial-Onset Seizures. Oxcarbazepine Oral Suspension Is Indicated For: Adults: Monotherapy Or Adjunctive Therapy In The Treatment Of Partial-Onset Seizures Pediatrics: - Monotherapy In The Treatment Of Partial-Onset Seizures In Children 4 To 16 Years - Adjunctive Therapy In The Treatment Of Partial-Onset Seizures In Children 2 To 16 Years. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Oxcarbazepine OXCARBAZEPINE ZINC4724

Comments